Bank of America’s Cue Biopharma CUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$221K Buy
324,584
+233
+0.1% +$159 ﹤0.01% 5187
2025
Q1
$295K Buy
324,351
+36
+0% +$33 ﹤0.01% 5009
2024
Q4
$354K Buy
324,315
+85,113
+36% +$92.8K ﹤0.01% 4945
2024
Q3
$181K Sell
239,202
-3,366
-1% -$2.55K ﹤0.01% 5203
2024
Q2
$301K Sell
242,568
-1,048
-0.4% -$1.3K ﹤0.01% 4867
2024
Q1
$460K Sell
243,616
-22,611
-8% -$42.7K ﹤0.01% 4597
2023
Q4
$703K Buy
266,227
+77,555
+41% +$205K ﹤0.01% 4396
2023
Q3
$434K Buy
188,672
+35,495
+23% +$81.6K ﹤0.01% 4576
2023
Q2
$559K Sell
153,177
-14,318
-9% -$52.3K ﹤0.01% 4420
2023
Q1
$598K Buy
167,495
+70,461
+73% +$252K ﹤0.01% 4513
2022
Q4
$277K Sell
97,034
-16,478
-15% -$47K ﹤0.01% 5027
2022
Q3
$253K Buy
113,512
+87,201
+331% +$194K ﹤0.01% 5064
2022
Q2
$65K Sell
26,311
-65,590
-71% -$162K ﹤0.01% 5914
2022
Q1
$449K Sell
91,901
-23,169
-20% -$113K ﹤0.01% 5199
2021
Q4
$1.3M Buy
115,070
+83,193
+261% +$941K ﹤0.01% 4300
2021
Q3
$464K Buy
31,877
+1,836
+6% +$26.7K ﹤0.01% 4912
2021
Q2
$350K Sell
30,041
-14,396
-32% -$168K ﹤0.01% 4957
2021
Q1
$542K Buy
44,437
+16,010
+56% +$195K ﹤0.01% 4683
2020
Q4
$356K Sell
28,427
-4,210
-13% -$52.7K ﹤0.01% 4536
2020
Q3
$491K Sell
32,637
-1,100
-3% -$16.5K ﹤0.01% 4173
2020
Q2
$827K Buy
33,737
+15,653
+87% +$384K ﹤0.01% 3784
2020
Q1
$257K Buy
18,084
+5,837
+48% +$83K ﹤0.01% 4396
2019
Q4
$194K Sell
12,247
-856
-7% -$13.6K ﹤0.01% 4876
2019
Q3
$111K Buy
13,103
+610
+5% +$5.17K ﹤0.01% 5184
2019
Q2
$112K Buy
12,493
+3,029
+32% +$27.2K ﹤0.01% 5187
2019
Q1
$74K Sell
9,464
-5,260
-36% -$41.1K ﹤0.01% 5271
2018
Q4
$69K Buy
14,724
+10,732
+269% +$50.3K ﹤0.01% 5337
2018
Q3
$36K Buy
3,992
+940
+31% +$8.48K ﹤0.01% 5591
2018
Q2
$37K Buy
3,052
+2,391
+362% +$29K ﹤0.01% 5550
2018
Q1
$9K Buy
+661
New +$9K ﹤0.01% 5876